BENRALIZUMAB

BENRALIZUMAB was reported 20994 times

These side effects are most commonly reported by patients taking BENRALIZUMAB:

# Side effect Count
0 ASTHMA 3144
1 DYSPNOEA 2109
2 DEATH 1738
3 DRUG INEFFECTIVE 1580
4 PNEUMONIA 1218
5 COUGH 1111
6 PRODUCT DOSE OMISSION ISSUE 1078
7 HEADACHE 973
8 WHEEZING 791
9 FATIGUE 679
10 MALAISE 638
11 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 619
12 ARTHRALGIA 581
13 PYREXIA 559
14 RASH 532
15 PAIN 514
16 PRURITUS 482
17 COVID-19 472
18 DIZZINESS 472
19 CONDITION AGGRAVATED 465
20 HYPERSENSITIVITY 462
21 DEVICE LEAKAGE 447
22 CHEST DISCOMFORT 431
23 LOWER RESPIRATORY TRACT INFECTION 430
24 URTICARIA 429
25 OFF LABEL USE 428
26 INJECTION SITE PAIN 413
27 FALL 406
28 ILLNESS 390
29 NAUSEA 360
30 FEELING ABNORMAL 305
31 HYPERTENSION 297
32 ASTHENIA 289
33 INFLUENZA 285
34 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 268
35 EOSINOPHIL COUNT INCREASED 260
36 NASOPHARYNGITIS 260
37 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 259
38 OROPHARYNGEAL PAIN 256
39 CHILLS 254
40 PAIN IN EXTREMITY 250
41 PRODUCTIVE COUGH 246
42 VOMITING 244
43 CEREBROVASCULAR ACCIDENT 243
44 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 241
45 INCORRECT DOSE ADMINISTERED BY DEVICE 240
46 PRODUCT USE ISSUE 240
47 SINUSITIS 240
48 MYALGIA 239
49 NASAL CONGESTION 230
50 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 218
51 BACK PAIN 213
52 DIARRHOEA 211
53 PERIPHERAL SWELLING 211
54 CHEST PAIN 210
55 LUNG DISORDER 204
56 GAIT DISTURBANCE 203
57 WEIGHT DECREASED 201
58 WEIGHT INCREASED 199
59 INFECTION 197
60 DYSPHONIA 192
61 MYOCARDIAL INFARCTION 192
62 DEVICE MALFUNCTION 181
63 OXYGEN SATURATION DECREASED 179
64 BRONCHITIS 173
65 ANAPHYLACTIC REACTION 169
66 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 169
67 URINARY TRACT INFECTION 160
68 ANXIETY 159
69 DRUG HYPERSENSITIVITY 158
70 NEOPLASM MALIGNANT 156
71 INSOMNIA 155
72 BLOOD PRESSURE INCREASED 153
73 DEVICE DELIVERY SYSTEM ISSUE 150
74 NEEDLE ISSUE 150
75 FULL BLOOD COUNT ABNORMAL 147
76 DRUG DOSE OMISSION BY DEVICE 146
77 HEART RATE INCREASED 146
78 ERYTHEMA 145
79 DEVICE ISSUE 142
80 OBSTRUCTIVE AIRWAYS DISORDER 140
81 CARDIAC DISORDER 138
82 MIGRAINE 133
83 INFLUENZA LIKE ILLNESS 132
84 PRODUCT USE IN UNAPPROVED INDICATION 131
85 DYSPNOEA EXERTIONAL 130
86 INCORRECT DOSE ADMINISTERED 130
87 MEMORY IMPAIRMENT 130
88 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 129
89 INSURANCE ISSUE 128
90 MUSCLE SPASMS 126
91 HERPES ZOSTER 125
92 TREMOR 121
93 ABDOMINAL PAIN 120
94 RHINORRHOEA 120
95 ATRIAL FIBRILLATION 116
96 SINUS DISORDER 115
97 DEPRESSION 113
98 PARAESTHESIA 113
99 VISUAL IMPAIRMENT 113
100 ALOPECIA 112
101 PALPITATIONS 111
102 THROMBOSIS 110
103 LOSS OF CONSCIOUSNESS 108
104 RASH PRURITIC 108
105 DEVICE USE ISSUE 107
106 DIABETES MELLITUS 107
107 HYPOTENSION 104
108 ILL-DEFINED DISORDER 104
109 NASAL POLYPS 104
110 ABDOMINAL PAIN UPPER 103
111 SYNCOPE 103
112 SWELLING 102
113 HYPOAESTHESIA 101
114 SWELLING FACE 101
115 THERAPEUTIC RESPONSE SHORTENED 101
116 EOSINOPHILIA 100
117 INJECTION SITE HAEMORRHAGE 100
118 SEPSIS 100
119 QUALITY OF LIFE DECREASED 98
120 ABDOMINAL DISCOMFORT 97
121 TACHYCARDIA 97
122 CONTUSION 95
123 ARTHRITIS 94
124 VIRAL INFECTION 94
125 DECREASED APPETITE 93
126 JOINT SWELLING 93
127 RESPIRATORY TRACT INFECTION 92
128 SOMNOLENCE 91
129 EXPOSURE DURING PREGNANCY 90
130 MIDDLE INSOMNIA 90
131 PULMONARY EMBOLISM 89
132 SPUTUM DISCOLOURED 89
133 CARDIAC FAILURE CONGESTIVE 88
134 ACCIDENTAL EXPOSURE TO PRODUCT 87
135 ASTHMATIC CRISIS 87
136 GENERAL PHYSICAL HEALTH DETERIORATION 87
137 RESPIRATORY FAILURE 86
138 BREAST CANCER 85
139 THERAPEUTIC PRODUCT EFFECT DECREASED 84
140 MATERNAL EXPOSURE DURING PREGNANCY 82
141 SECRETION DISCHARGE 82
142 SNEEZING 82
143 SYMPTOM RECURRENCE 82
144 CATARACT 81
145 INJECTION SITE ERYTHEMA 81
146 RESPIRATORY TRACT CONGESTION 81
147 FEELING HOT 80
148 GASTROINTESTINAL DISORDER 80
149 SEIZURE 80
150 SLEEP DISORDER 80
151 NEUROPATHY PERIPHERAL 78
152 CONFUSIONAL STATE 77
153 CARDIAC FAILURE 76
154 MUSCULAR WEAKNESS 76
155 DEMENTIA 75
156 PRODUCT DOSE OMISSION 74
157 BRONCHOSPASM 73
158 NEPHROLITHIASIS 73
159 RESPIRATORY DISORDER 73
160 THROAT IRRITATION 73
161 THROAT TIGHTNESS 73
162 PULMONARY CONGESTION 72
163 DECREASED ACTIVITY 71
164 MULTIPLE ALLERGIES 71
165 DEVICE DEFECTIVE 70
166 IMPAIRED QUALITY OF LIFE 70
167 RHEUMATOID ARTHRITIS 70
168 INJECTION SITE REACTION 69
169 DYSPHAGIA 68
170 FLUSHING 68
171 INTENTIONAL PRODUCT MISUSE 68
172 BLINDNESS 67
173 GASTROOESOPHAGEAL REFLUX DISEASE 67
174 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67
175 PULMONARY OEDEMA 66
176 MOBILITY DECREASED 65
177 CELLULITIS 64
178 ABORTION SPONTANEOUS 63
179 BONE PAIN 63
180 INFLAMMATION 63
181 OEDEMA PERIPHERAL 63
182 STRESS 63
183 EOSINOPHIL COUNT ABNORMAL 62
184 NO ADVERSE EVENT 62
185 PULMONARY MASS 62
186 UPPER LIMB FRACTURE 62
187 HYPERHIDROSIS 61
188 RHINITIS 61
189 SPEECH DISORDER 60
190 UPPER RESPIRATORY TRACT INFECTION 60
191 ANGIOEDEMA 59
192 DISCOMFORT 59
193 PNEUMONITIS 59
194 VISION BLURRED 59
195 ABDOMINAL DISTENSION 58
196 WRIST FRACTURE 58
197 SEASONAL ALLERGY 57
198 BLOOD PRESSURE DECREASED 56
199 ECZEMA 56
200 LUNG NEOPLASM MALIGNANT 56
201 PRODUCT DISTRIBUTION ISSUE 56
202 ANAEMIA 55
203 BRONCHIECTASIS 55
204 DRUG EFFECT LESS THAN EXPECTED 55
205 HYPOACUSIS 55
206 LYMPHADENOPATHY 55
207 BURNING SENSATION 54
208 HOSPITALISATION 54
209 INJECTION SITE BRUISING 54
210 HAEMORRHAGE 53
211 FLUID RETENTION 52
212 INTERVERTEBRAL DISC PROTRUSION 52
213 NECK PAIN 52
214 PSEUDOMONAS INFECTION 52
215 EYE PRURITUS 51
216 PHARYNGEAL SWELLING 51
217 DEAFNESS 50
218 DRY MOUTH 50
219 INJECTION SITE SWELLING 50
220 NERVOUSNESS 50
221 ADVERSE DRUG REACTION 49
222 CONJUNCTIVITIS 49
223 LIP SWELLING 49
224 OROPHARYNGEAL DISCOMFORT 49
225 RENAL FAILURE 49
226 BLOOD GLUCOSE INCREASED 48
227 ANOSMIA 47
228 DIVERTICULITIS 47
229 EOSINOPHIL COUNT DECREASED 47
230 HAEMOPTYSIS 47
231 HERNIA 47
232 BRONCHIAL SECRETION RETENTION 46
233 KIDNEY INFECTION 46
234 MUSCULOSKELETAL STIFFNESS 46
235 PHARYNGITIS 46
236 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46
237 VASCULITIS 46
238 ADRENAL INSUFFICIENCY 45
239 EPISTAXIS 45
240 INJECTION SITE PRURITUS 45
241 PNEUMOTHORAX 45
242 RIB FRACTURE 45
243 CARDIAC ARREST 44
244 INJURY ASSOCIATED WITH DEVICE 44
245 MENTAL DISORDER 44
246 OSTEOPOROSIS 44
247 PULMONARY FUNCTION TEST DECREASED 44
248 RALES 44
249 SWOLLEN TONGUE 44
250 THERAPY INTERRUPTED 44
251 BALANCE DISORDER 43
252 BLOOD IMMUNOGLOBULIN E INCREASED 43
253 ATRIAL FLUTTER 42
254 VERTIGO 42
255 BRONCHIAL OBSTRUCTION 41
256 DEHYDRATION 41
257 DISEASE RECURRENCE 41
258 LIMB INJURY 41
259 PLEURAL EFFUSION 41
260 PRODUCT ADMINISTRATION ERROR 41
261 THERAPY CESSATION 41
262 BLOOD COUNT ABNORMAL 40
263 CONSTIPATION 40
264 PANCREATITIS 40
265 RASH ERYTHEMATOUS 40
266 SUICIDAL IDEATION 40
267 APHONIA 39
268 BACTERIAL DISEASE CARRIER 39
269 DYSPEPSIA 39
270 FEELING COLD 39
271 GAIT INABILITY 39
272 HIP FRACTURE 39
273 RESPIRATION ABNORMAL 39
274 SPINAL CORD COMPRESSION 39
275 TRANSIENT ISCHAEMIC ATTACK 39
276 CHOKING 38
277 COLITIS 38
278 DRY SKIN 38
279 EXERCISE TOLERANCE DECREASED 38
280 HYPOXIA 38
281 OEDEMA 38
282 RENAL DISORDER 38
283 INJECTION SITE RASH 37
284 INTENTIONAL PRODUCT USE ISSUE 37
285 PARAESTHESIA ORAL 37
286 RESPIRATORY DISTRESS 37
287 ARRHYTHMIA 36
288 BLOOD PRESSURE ABNORMAL 36
289 BRONCHIAL WALL THICKENING 36
290 EYE PAIN 36
291 TINNITUS 36
292 HOT FLUSH 35
293 HYPERVENTILATION 35
294 INTESTINAL OBSTRUCTION 35
295 PULMONARY FIBROSIS 35
296 EMPHYSEMA 34
297 OSTEOARTHRITIS 34
298 DRY EYE 33
299 PROSTATE CANCER 33
300 WHITE BLOOD CELL COUNT INCREASED 33
301 AGEUSIA 32
302 ANAPHYLACTIC SHOCK 32
303 DEMENTIA ALZHEIMER^S TYPE 32
304 FORCED EXPIRATORY VOLUME DECREASED 32
305 INCREASED BRONCHIAL SECRETION 32
306 INJECTION SITE MASS 32
307 INJECTION SITE URTICARIA 32
308 LIMB DISCOMFORT 32
309 LOWER LIMB FRACTURE 32
310 OLIGOHYDRAMNIOS 32
311 ANGINA PECTORIS 31
312 BLISTER 31
313 CYSTITIS 31
314 DEPRESSED MOOD 31
315 FOOT FRACTURE 31
316 INJECTION SITE EXTRAVASATION 31
317 RHINOVIRUS INFECTION 31
318 ROAD TRAFFIC ACCIDENT 31
319 BACTERIAL INFECTION 30
320 BLOOD GLUCOSE DECREASED 30
321 DEEP VEIN THROMBOSIS 30
322 EAR INFECTION 30
323 EYE SWELLING 30
324 INABILITY TO AFFORD MEDICATION 30
325 INTENTIONAL DOSE OMISSION 30
326 PSORIASIS 30
327 SKIN DISCOLOURATION 30
328 CHOLELITHIASIS 29
329 OCULAR HYPERAEMIA 29
330 RHINITIS ALLERGIC 29
331 SARS-COV-2 TEST POSITIVE 29
332 SLEEP APNOEA SYNDROME 29
333 THERAPEUTIC RESPONSE DECREASED 29
334 ADVERSE EVENT 28
335 AUTOIMMUNE DISORDER 28
336 BREAST CANCER FEMALE 28
337 DERMATITIS 28
338 DERMATITIS ATOPIC 28
339 DISEASE PROGRESSION 28
340 EYE DISORDER 28
341 HEAD INJURY 28
342 LACRIMATION INCREASED 28
343 LETHARGY 28
344 NEURALGIA 28
345 OBESITY 28
346 PNEUMONIA BACTERIAL 28
347 PRODUCT DOSE OMISSION IN ERROR 28
348 UPPER-AIRWAY COUGH SYNDROME 28
349 APHASIA 27
350 EYE IRRITATION 27
351 FIBROMYALGIA 27
352 MEDICATION ERROR 27
353 MOVEMENT DISORDER 27
354 RENAL IMPAIRMENT 27
355 SPINAL FRACTURE 27
356 WHITE BLOOD CELL COUNT DECREASED 27
357 AMNESIA 26
358 ARTHROPATHY 26
359 BODY TEMPERATURE INCREASED 26
360 CEREBRAL HAEMORRHAGE 26
361 COLON CANCER 26
362 EOSINOPHILIC PNEUMONIA 26
363 EPILEPSY 26
364 FOETAL GROWTH RESTRICTION 26
365 PRODUCT STORAGE ERROR 26
366 THERAPEUTIC RESPONSE UNEXPECTED 26
367 ANKLE FRACTURE 25
368 COLITIS ULCERATIVE 25
369 DRUG INTOLERANCE 25
370 FOETAL EXPOSURE DURING PREGNANCY 25
371 FUNGAL INFECTION 25
372 GALLBLADDER DISORDER 25
373 LABORATORY TEST ABNORMAL 25
374 NERVOUS SYSTEM DISORDER 25
375 SINUS CONGESTION 25
376 TYPE 2 DIABETES MELLITUS 25
377 ACNE 24
378 C-REACTIVE PROTEIN INCREASED 24
379 CANDIDA INFECTION 24
380 DYSGEUSIA 24
381 HAEMOGLOBIN DECREASED 24
382 HEART RATE DECREASED 24
383 JOINT INJURY 24
384 LIVER DISORDER 24
385 MUSCULOSKELETAL DISCOMFORT 24
386 PRESYNCOPE 24
387 RASH MACULAR 24
388 SKIN EXFOLIATION 24
389 THERAPY CHANGE 24
390 THERAPY NON-RESPONDER 24
391 THROMBOCYTOPENIA 24
392 ASPERGILLUS INFECTION 23
393 CHRONIC KIDNEY DISEASE 23
394 COVID-19 PNEUMONIA 23
395 DISTURBANCE IN ATTENTION 23
396 DYSARTHRIA 23
397 HEAD DISCOMFORT 23
398 IMMUNE SYSTEM DISORDER 23
399 IMMUNODEFICIENCY 23
400 PANCREATIC CARCINOMA 23
401 PNEUMONIA ASPIRATION 23
402 SEPTIC SHOCK 23
403 TREATMENT NONCOMPLIANCE 23
404 WOUND 23
405 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22
406 CYSTIC FIBROSIS 22
407 DYSSTASIA 22
408 INJECTION SITE DISCHARGE 22
409 LARYNGITIS 22
410 LOCALISED INFECTION 22
411 RESPIRATORY RATE INCREASED 22
412 STAPHYLOCOCCAL INFECTION 22
413 WEIGHT FLUCTUATION 22
414 JOINT STIFFNESS 21
415 MENTAL IMPAIRMENT 21
416 PANIC ATTACK 21
417 PERICARDIAL EFFUSION 21
418 PLATELET COUNT DECREASED 21
419 PRODUCT PRESCRIBING ISSUE 21
420 PRODUCT QUALITY ISSUE 21
421 PULMONARY THROMBOSIS 21
422 SERUM SICKNESS 21
423 SKIN DISORDER 21
424 BRAIN FOG 20
425 COLD SWEAT 20
426 DYSURIA 20
427 FEMUR FRACTURE 20
428 GASTRITIS 20
429 GLAUCOMA 20
430 HEPATIC ENZYME INCREASED 20
431 INTENTIONAL DEVICE MISUSE 20
432 MACULAR DEGENERATION 20
433 NIGHT SWEATS 20
434 ORAL HERPES 20
435 POLYP 20
436 PULMONARY HYPERTENSION 20
437 SKIN IRRITATION 20
438 SKIN LESION 20
439 UNEVALUABLE EVENT 20
440 ACUTE RESPIRATORY FAILURE 19
441 ASPHYXIA 19
442 BRAIN MALFORMATION 19
443 CEREBRAL VENTRICLE DILATATION 19
444 CHRONIC SINUSITIS 19
445 COMA 19
446 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 19
447 DEVICE USE ERROR 19
448 EATING DISORDER 19
449 EMOTIONAL DISTRESS 19
450 EXPOSURE VIA SKIN CONTACT 19
451 HYPERSOMNIA 19
452 HYPOTHYROIDISM 19
453 INJECTION SITE DISCOMFORT 19
454 INJECTION SITE INDENTATION 19
455 INJURY 19
456 MASS 19
457 SKIN LACERATION 19
458 BLOOD IRON DECREASED 18
459 BLOOD SODIUM DECREASED 18
460 BODY HEIGHT DECREASED 18
461 CARPAL TUNNEL SYNDROME 18
462 DEVICE BREAKAGE 18
463 DRUG INTERACTION 18
464 FOOD ALLERGY 18
465 HAEMATOLOGICAL INFECTION 18
466 HIATUS HERNIA 18
467 HYPEREOSINOPHILIC SYNDROME 18
468 MUSCULOSKELETAL CHEST PAIN 18
469 SENSORY DISTURBANCE 18
470 SYSTEMIC LUPUS ERYTHEMATOSUS 18
471 TASTE DISORDER 18
472 ASPIRATION 17
473 BACK DISORDER 17
474 BLOOD POTASSIUM DECREASED 17
475 CEREBRAL DISORDER 17
476 CEREBRAL INFARCTION 17
477 COGNITIVE DISORDER 17
478 DEVICE DIFFICULT TO USE 17
479 EAR PAIN 17
480 FRACTURE 17
481 GENERAL SYMPTOM 17
482 HYPOKINESIA 17
483 INJECTION SITE INJURY 17
484 INTERSTITIAL LUNG DISEASE 17
485 MUSCULOSKELETAL PAIN 17
486 OBSTRUCTIVE SLEEP APNOEA SYNDROME 17
487 PARKINSON^S DISEASE 17
488 POLYNEUROPATHY 17
489 SKIN CANCER 17
490 ACCIDENT 16
491 ATYPICAL PNEUMONIA 16
492 BLOOD TEST ABNORMAL 16
493 BRAIN NEOPLASM 16
494 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16
495 DEVICE PHYSICAL PROPERTY ISSUE 16
496 DRUG EFFECT DECREASED 16
497 GASTROENTERITIS 16
498 GASTROINTESTINAL HAEMORRHAGE 16
499 GENERALISED OEDEMA 16
500 HYPOAESTHESIA ORAL 16
501 IMPAIRED GASTRIC EMPTYING 16
502 INFUSION SITE SWELLING 16
503 LUNG INFILTRATION 16
504 MYCOBACTERIUM AVIUM COMPLEX INFECTION 16
505 PNEUMONIA FUNGAL 16
506 PNEUMONIA PSEUDOMONAL 16
507 SKIN BURNING SENSATION 16
508 SKIN INFECTION 16
509 SKIN ULCER 16
510 SURGERY 16
511 ACUTE KIDNEY INJURY 15
512 ACUTE MYOCARDIAL INFARCTION 15
513 BLINDNESS UNILATERAL 15
514 BLOOD CHOLESTEROL INCREASED 15
515 DEVICE FAILURE 15
516 ECTOPIC PREGNANCY 15
517 FEAR 15
518 FLATULENCE 15
519 GASTROENTERITIS VIRAL 15
520 HEART RATE IRREGULAR 15
521 HEPATIC STEATOSIS 15
522 HEREDITARY ANGIOEDEMA 15
523 HYPOPHAGIA 15
524 INFUSION RELATED REACTION 15
525 INJECTION SITE DISCOLOURATION 15
526 ISCHAEMIC STROKE 15
527 MALIGNANT NEOPLASM PROGRESSION 15
528 MATERNAL EXPOSURE BEFORE PREGNANCY 15
529 NASAL DISORDER 15
530 OSTEOMYELITIS 15
531 POLLAKIURIA 15
532 POST PROCEDURAL COMPLICATION 15
533 PRODUCT AVAILABILITY ISSUE 15
534 PULMONARY FUNCTION TEST ABNORMAL 15
535 SARS-COV-2 TEST NEGATIVE 15
536 SKIN REACTION 15
537 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 15
538 TREATMENT DELAYED 15
539 TREATMENT FAILURE 15
540 AGITATION 14
541 BIPOLAR DISORDER 14
542 BLADDER CANCER 14
543 CARDIAC MURMUR 14
544 CLOSTRIDIUM DIFFICILE INFECTION 14
545 DERMATITIS CONTACT 14
546 DRUG DELIVERY SYSTEM ISSUE 14
547 EYE HAEMORRHAGE 14
548 HYPONATRAEMIA 14
549 IRRITABLE BOWEL SYNDROME 14
550 LUNG OPACITY 14
551 PAIN IN JAW 14
552 POOR QUALITY SLEEP 14
553 RESTLESSNESS 14
554 APPENDICITIS 13
555 BRAIN INJURY 13
556 BRONCHOPULMONARY ASPERGILLOSIS 13
557 DRUG DEPENDENCE 13
558 EYE INFECTION 13
559 FACE OEDEMA 13
560 FACIAL PARALYSIS 13
561 FEEDING DISORDER 13
562 GASTRIC ULCER 13
563 GOUT 13
564 HAEMATOCHEZIA 13
565 HALLUCINATION 13
566 INCORRECT DOSE ADMINISTERED BY PRODUCT 13
567 MOUTH SWELLING 13
568 MULTIPLE SCLEROSIS 13
569 MUSCLE STRAIN 13
570 NODULE 13
571 ORAL CANDIDIASIS 13
572 PAROSMIA 13
573 POST-ACUTE COVID-19 SYNDROME 13
574 RESPIRATORY ARREST 13
575 SNORING 13
576 STREPTOCOCCAL INFECTION 13
577 THYROID DISORDER 13
578 ADVERSE REACTION 12
579 ARTERIOSPASM CORONARY 12
580 ARTHRITIS INFECTIVE 12
581 BREATH SOUNDS ABNORMAL 12
582 BURSITIS 12
583 CRYING 12
584 DERMATITIS ALLERGIC 12
585 DRY THROAT 12
586 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 12
587 GUILLAIN-BARRE SYNDROME 12
588 HAEMATOMA 12
589 HEPATIC CANCER 12
590 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12
591 INFUSION SITE ERYTHEMA 12
592 IRRITABILITY 12
593 LARYNGEAL OEDEMA 12
594 MALIGNANT MELANOMA 12
595 MYASTHENIA GRAVIS 12
596 NEOPLASM 12
597 ORGANISING PNEUMONIA 12
598 OXYGEN SATURATION ABNORMAL 12
599 PRODUCT DISPENSING ERROR 12
600 PRODUCT LEAKAGE 12
601 PRODUCT PACKAGING ISSUE 12
602 RASH PAPULAR 12
603 RESPIRATORY SYMPTOM 12
604 RESTLESS LEGS SYNDROME 12
605 SCRATCH 12
606 SENSITIVE SKIN 12
607 STOMATITIS 12
608 TOTAL LUNG CAPACITY DECREASED 12
609 ABDOMINAL PAIN LOWER 11
610 ADDISON^S DISEASE 11
611 ANEURYSM 11
612 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11
613 ATELECTASIS 11
614 ATRIOVENTRICULAR BLOCK 11
615 BLOOD PRESSURE FLUCTUATION 11
616 BODY MASS INDEX INCREASED 11
617 BRONCHITIS CHRONIC 11
618 CORONARY ARTERY OCCLUSION 11
619 CROHN^S DISEASE 11
620 DEAFNESS UNILATERAL 11
621 DRUG DOSE OMISSION 11
622 DRUG ERUPTION 11
623 EAR DISCOMFORT 11
624 EOSINOPHILIC OTITIS MEDIA 11
625 FEV1/FVC RATIO DECREASED 11
626 FRUSTRATION TOLERANCE DECREASED 11
627 GASTROINTESTINAL INFECTION 11
628 HAEMATEMESIS 11
629 MULTIPLE FRACTURES 11
630 NEAR DEATH EXPERIENCE 11
631 NERVE COMPRESSION 11
632 NOCTURNAL DYSPNOEA 11
633 OBSTRUCTION 11
634 PALLOR 11
635 PEMPHIGOID 11
636 POLYMYALGIA RHEUMATICA 11
637 PRURITUS GENERALISED 11
638 PSORIATIC ARTHROPATHY 11
639 PURPURA 11
640 REBOUND EFFECT 11
641 SENSATION OF FOREIGN BODY 11
642 SHOULDER FRACTURE 11
643 SKIN MASS 11
644 TENDERNESS 11
645 TERMINAL STATE 11
646 TOOTH INFECTION 11
647 URINARY RETENTION 11
648 BLOOD GLUCOSE ABNORMAL 10
649 BLOOD POTASSIUM INCREASED 10
650 CYST 10
651 DISORIENTATION 10
652 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10
653 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10
654 DYSKINESIA 10
655 EAR DISORDER 10
656 EOSINOPHIL COUNT 10
657 EOSINOPHILIC OESOPHAGITIS 10
658 FACIAL PAIN 10
659 FEAR OF INJECTION 10
660 HYPOGLYCAEMIA 10
661 IMPAIRED HEALING 10
662 JOINT DISLOCATION 10
663 MEAN CELL VOLUME INCREASED 10
664 MUSCLE TIGHTNESS 10
665 NEUTROPENIA 10
666 OCULAR DISCOMFORT 10
667 ORAL DISCOMFORT 10
668 OSTEOPENIA 10
669 OVERDOSE 10
670 PERIPHERAL COLDNESS 10
671 PNEUMOCYSTIS JIROVECII INFECTION 10
672 PULMONARY PAIN 10
673 RHONCHI 10
674 SARCOIDOSIS 10
675 SCAB 10
676 SCAR 10
677 SCIATICA 10
678 SKIN ABRASION 10
679 SUPRAVENTRICULAR TACHYCARDIA 10
680 SUSPECTED COVID-19 10
681 SWELLING OF EYELID 10
682 TACHYPNOEA 10
683 URINARY INCONTINENCE 10
684 WRONG PRODUCT ADMINISTERED 10
685 ANAL INCONTINENCE 9
686 ANGIOPATHY 9
687 AORTIC ANEURYSM 9
688 ARTERIOSCLEROSIS 9
689 BACTERAEMIA 9
690 BLOOD PRESSURE DIASTOLIC INCREASED 9
691 BREAST MASS 9
692 CARDIOMYOPATHY 9
693 CHOLECYSTITIS 9
694 CHRONIC EOSINOPHILIC RHINOSINUSITIS 9
695 COMPRESSION FRACTURE 9
696 CONCUSSION 9
697 DISABILITY 9
698 FEELING JITTERY 9
699 HYPERTHYROIDISM 9
700 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9
701 INFUSION SITE PAIN 9
702 LEUKAEMIA 9
703 LIQUID PRODUCT PHYSICAL ISSUE 9
704 LUMBAR VERTEBRAL FRACTURE 9
705 LYMPHOMA 9
706 MENINGITIS 9
707 MOUTH ULCERATION 9
708 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9
709 NERVE INJURY 9
710 NEUTROPHIL COUNT DECREASED 9
711 NIGHTMARE 9
712 PEAK EXPIRATORY FLOW RATE DECREASED 9
713 PELVIC FRACTURE 9
714 PHARYNGITIS STREPTOCOCCAL 9
715 PLASMA CELL MYELOMA 9
716 POST-TRAUMATIC STRESS DISORDER 9
717 PREMATURE BABY 9
718 PROCEDURAL PAIN 9
719 PRODUCT DELIVERY MECHANISM ISSUE 9
720 PRODUCT LABEL ISSUE 9
721 RASH GENERALISED 9
722 RASH VESICULAR 9
723 RENAL CANCER 9
724 RHABDOMYOLYSIS 9
725 SENSE OF OPPRESSION 9
726 SINUS POLYP 9
727 SJOGREN^S SYNDROME 9
728 SKIN HAEMORRHAGE 9
729 SPINAL PAIN 9
730 SPUTUM INCREASED 9
731 SUICIDAL BEHAVIOUR 9
732 TEMPERATURE INTOLERANCE 9
733 THYROID CANCER 9
734 TOOTHACHE 9
735 TRACHEOMALACIA 9
736 VITREOUS FLOATERS 9
737 ACTIVITIES OF DAILY LIVING DECREASED 8
738 ACUTE RESPIRATORY DISTRESS SYNDROME 8
739 ALLERGY TO ANIMAL 8
740 ARTERIAL OCCLUSIVE DISEASE 8
741 BACK INJURY 8
742 BLOOD PRESSURE SYSTOLIC INCREASED 8
743 BONE DISORDER 8
744 CARDIAC FLUTTER 8
745 CARDIOVASCULAR DISORDER 8
746 CLAVICLE FRACTURE 8
747 CORONARY ARTERY DISEASE 8
748 CORONAVIRUS INFECTION 8
749 DELIRIUM 8
750 DIPLOPIA 8
751 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8
752 EMOTIONAL DISORDER 8
753 EXPIRED PRODUCT ADMINISTERED 8
754 EXTRA DOSE ADMINISTERED 8
755 FOOD INTOLERANCE 8
756 GASTRIC CANCER 8
757 GLUCOSE TOLERANCE IMPAIRED 8
758 HAEMATURIA 8
759 HAEMORRHOIDS 8
760 HEMIPARESIS 8
761 HEPATIC FUNCTION ABNORMAL 8
762 INFECTION PARASITIC 8
763 INFECTIVE EXACERBATION OF ASTHMA 8
764 INFUSION SITE PRURITUS 8
765 INJECTION RELATED REACTION 8
766 INJECTION SITE NODULE 8
767 INTESTINAL ISCHAEMIA 8
768 INTRACRANIAL ANEURYSM 8
769 IRON DEFICIENCY 8
770 LIGAMENT SPRAIN 8
771 MAST CELL ACTIVATION SYNDROME 8
772 MENINGITIS ASEPTIC 8
773 MIGRAINE WITH AURA 8
774 ORAL DISORDER 8
775 ORAL PAIN 8
776 OSTEONECROSIS 8
777 OVERWEIGHT 8
778 PAIN OF SKIN 8
779 PANCREATITIS ACUTE 8
780 PLEURISY 8
781 PNEUMONIA INFLUENZAL 8
782 POSTOPERATIVE WOUND INFECTION 8
783 PREMATURE DELIVERY 8
784 PRODUCT SUPPLY ISSUE 8
785 PYELONEPHRITIS 8
786 RENAL CYST 8
787 SOCIAL PROBLEM 8
788 SPIROMETRY ABNORMAL 8
789 STATUS EPILEPTICUS 8
790 SYRINGE ISSUE 8
791 TENDON RUPTURE 8
792 THERAPEUTIC PRODUCT INEFFECTIVE 8
793 THIRST 8
794 THORACIC VERTEBRAL FRACTURE 8
795 UNDERDOSE 8
796 VENTRICULAR EXTRASYSTOLES 8
797 VOCAL CORD DISORDER 8
798 ADMINISTRATION SITE PAIN 7
799 ADRENOCORTICAL INSUFFICIENCY ACUTE 7
800 ARTHROPOD BITE 7
801 ASPARTATE AMINOTRANSFERASE INCREASED 7
802 BASAL CELL CARCINOMA 7
803 BILIARY COLIC 7
804 BLOOD IMMUNOGLOBULIN G INCREASED 7
805 BODY TEMPERATURE ABNORMAL 7
806 BRONCHIOLITIS 7
807 CAPUT SUCCEDANEUM 7
808 CARDIAC VALVE DISEASE 7
809 CARDIO-RESPIRATORY ARREST 7
810 CARTILAGE INJURY 7
811 CHEST INJURY 7
812 CHOLESTASIS 7
813 CUTANEOUS VASCULITIS 7
814 CYTOKINE STORM 7
815 DEVICE DISPENSING ERROR 7
816 DRUG ABUSE 7
817 EOSINOPHILIC PNEUMONIA CHRONIC 7
818 ERYTHEMA MULTIFORME 7
819 FOOT DEFORMITY 7
820 GRIP STRENGTH DECREASED 7
821 GROIN PAIN 7
822 HAND FRACTURE 7
823 HEPATIC CIRRHOSIS 7
824 HYPERPYREXIA 7
825 HYPERSENSITIVITY PNEUMONITIS 7
826 HYPOKALAEMIA 7
827 HYPOSMIA 7
828 IMMUNE THROMBOCYTOPENIA 7
829 IMMUNOSUPPRESSION 7
830 INCORRECT DISPOSAL OF PRODUCT 7
831 INCORRECT PRODUCT ADMINISTRATION DURATION 7
832 INFUSION SITE BRUISING 7
833 INFUSION SITE DISCHARGE 7
834 INJECTION SITE WARMTH 7
835 JAUNDICE NEONATAL 7
836 LEUKOPENIA 7
837 LOWER RESPIRATORY TRACT CONGESTION 7
838 LYME DISEASE 7
839 METASTASES TO LUNG 7
840 MOOD ALTERED 7
841 MYCOPLASMA INFECTION 7
842 NASAL DRYNESS 7
843 NECK MASS 7
844 OESOPHAGEAL CARCINOMA 7
845 ORAL PRURITUS 7
846 PARALYSIS 7
847 PARANASAL SINUS DISCOMFORT 7
848 PERICARDITIS 7
849 PERIORBITAL SWELLING 7
850 PHLEBITIS 7
851 PHOTOPHOBIA 7
852 PNEUMONIA PNEUMOCOCCAL 7
853 PNEUMONIA STAPHYLOCOCCAL 7
854 PREMATURE RUPTURE OF MEMBRANES 7
855 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7
856 PRODUCT PREPARATION ERROR 7
857 PULMONARY GRANULOMA 7
858 RED BLOOD CELL COUNT DECREASED 7
859 RENAL PAIN 7
860 RESPIRATORY TRACT IRRITATION 7
861 ROTATOR CUFF SYNDROME 7
862 SKIN ATROPHY 7
863 SLOW SPEECH 7
864 SUICIDE ATTEMPT 7
865 THROAT CANCER 7
866 TUBERCULOSIS 7
867 UNRESPONSIVE TO STIMULI 7
868 VAGINAL HAEMORRHAGE 7
869 VITAMIN B12 DEFICIENCY 7
870 WHITE BLOOD CELL COUNT ABNORMAL 7
871 ABDOMINAL HERNIA 6
872 ABORTION 6
873 ACUTE CORONARY SYNDROME 6
874 ALANINE AMINOTRANSFERASE INCREASED 6
875 APHTHOUS ULCER 6
876 BELL^S PALSY 6
877 BLADDER DISORDER 6
878 BLOOD CALCIUM INCREASED 6
879 BLOOD CREATINE PHOSPHOKINASE INCREASED 6
880 BLOOD TRIGLYCERIDES INCREASED 6
881 BRADYCARDIA 6
882 CARDITIS 6
883 CYANOSIS 6
884 DERMATITIS BULLOUS 6
885 DEVICE MECHANICAL ISSUE 6
886 DEVICE OPERATIONAL ISSUE 6
887 DEVICE RELATED INFECTION 6
888 DRUG SPECIFIC ANTIBODY PRESENT 6
889 EMPYEMA 6
890 EOSINOPHILIC MYOCARDITIS 6
891 ERUCTATION 6
892 ESSENTIAL HYPERTENSION 6
893 EXPOSURE TO SARS-COV-2 6
894 FORCED EXPIRATORY VOLUME ABNORMAL 6
895 FRACTURED COCCYX 6
896 FREQUENT BOWEL MOVEMENTS 6
897 FULL BLOOD COUNT DECREASED 6
898 GASTRIC DISORDER 6
899 GASTRIC HAEMORRHAGE 6
900 GOITRE 6
901 HALLUCINATION, VISUAL 6
902 HEART RATE ABNORMAL 6
903 HEMIPLEGIA 6
904 HERPES VIRUS INFECTION 6
905 HYPERLIPIDAEMIA 6
906 HYPERSENSITIVITY VASCULITIS 6
907 INITIAL INSOMNIA 6
908 INTENTIONAL OVERDOSE 6
909 INTENTIONAL SELF-INJURY 6
910 INTERNAL HAEMORRHAGE 6
911 INTESTINAL PERFORATION 6
912 KNEE ARTHROPLASTY 6
913 LOCAL REACTION 6
914 LUNG TRANSPLANT 6
915 LYMPHOEDEMA 6
916 MAJOR DEPRESSION 6
917 MENINGIOMA 6
918 MENISCUS INJURY 6
919 METASTASES TO LIVER 6
920 MONOCYTE COUNT INCREASED 6
921 MONOPLEGIA 6
922 MOTOR DYSFUNCTION 6
923 MYOSITIS 6
924 NASAL DISCOMFORT 6
925 NEURITIS 6
926 ORGAN FAILURE 6
927 ORTHOPNOEA 6
928 OXYGEN THERAPY 6
929 PAPULE 6
930 PATELLA FRACTURE 6
931 PERIPHERAL VENOUS DISEASE 6
932 PHARYNGEAL OEDEMA 6
933 PHOTOSENSITIVITY REACTION 6
934 PHYSICAL DECONDITIONING 6
935 PIGMENTATION DISORDER 6
936 PNEUMONIA VIRAL 6
937 POSTMENOPAUSAL HAEMORRHAGE 6
938 RECTAL HAEMORRHAGE 6
939 RESPIRATORY TRACT INFECTION VIRAL 6
940 RETCHING 6
941 RETINAL ARTERY OCCLUSION 6
942 RETINAL HAEMORRHAGE 6
943 RUBBER SENSITIVITY 6
944 SENSITIVITY TO WEATHER CHANGE 6
945 SINONASAL OBSTRUCTION 6
946 SINUS PAIN 6
947 SKIN FISSURES 6
948 SKIN INJURY 6
949 SKIN SWELLING 6
950 SPINAL DISORDER 6
951 SPINAL OSTEOARTHRITIS 6
952 STEVENS-JOHNSON SYNDROME 6
953 SUBARACHNOID HAEMORRHAGE 6
954 SUFFOCATION FEELING 6
955 TEMPOROMANDIBULAR JOINT SYNDROME 6
956 TENDON DISORDER 6
957 THINKING ABNORMAL 6
958 THROAT CLEARING 6
959 TOXICITY TO VARIOUS AGENTS 6
960 TRIGGER FINGER 6
961 TYPE III IMMUNE COMPLEX MEDIATED REACTION 6
962 ULCER 6
963 UMBILICAL HERNIA 6
964 UPPER RESPIRATORY TRACT CONGESTION 6
965 VITAMIN D DECREASED 6
966 WOUND INFECTION 6
967 ACQUIRED HAEMOPHILIA 5
968 ACUTE SINUSITIS 5
969 ALLERGY TO CHEMICALS 5
970 ALTERED STATE OF CONSCIOUSNESS 5
971 AMYOTROPHIC LATERAL SCLEROSIS 5
972 ANAPHYLACTOID REACTION 5
973 ANTINUCLEAR ANTIBODY POSITIVE 5
974 APNOEA 5
975 ARTERIAL DISORDER 5
976 BLASTOMYCOSIS 5
977 BLOOD DISORDER 5
978 BLOOD IMMUNOGLOBULIN G DECREASED 5
979 BODY TEMPERATURE DECREASED 5
980 BOWEL MOVEMENT IRREGULARITY 5
981 BREAST CANCER RECURRENT 5
982 BREAST CANCER STAGE I 5
983 BREAST NEOPLASM 5
984 BREAST PAIN 5
985 CARBOHYDRATE ANTIGEN 19-9 INCREASED 5
986 CARBON DIOXIDE INCREASED 5
987 CARDIAC FAILURE CHRONIC 5
988 CEREBRAL ISCHAEMIA 5
989 CHEILITIS 5
990 CHOLECYSTITIS INFECTIVE 5
991 CHRONIC RESPIRATORY FAILURE 5
992 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 5
993 COAGULOPATHY 5
994 COMPLICATION ASSOCIATED WITH DEVICE 5
995 CONJUNCTIVITIS ALLERGIC 5
996 CRANIOCEREBRAL INJURY 5
997 CREPITATIONS 5
998 CRITICAL ILLNESS 5
999 CROUP INFECTIOUS 5